bs-2495R-Cy7 [Conjugated Primary Antibody]
CD30 Polyclonal Antibody, Cy7 Conjugated
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: CD30

Immunogen Range: 131-230/595


Clonality: Polyclonal

Isotype: IgG

Entrez Gene: 943

Swiss Prot: P28908

Source: KLH conjugated synthetic peptide derived from human CD30

Purification: Purified by Protein A.

Storage Buffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Background:

Receptor for TNFSF8/CD3L. May play a role in the regulation of cellular growth and transformation of activated lymphoblasts. Regulates gene expression through activation of NF-kappa-B.

Conjugation: Cy7

Excitation/ Emission: 743nm/767nm

Size: 100ul

Concentration: 1ug/ul

Applications: WB(1:300-5000)
FCM(1:20-100)
IF(IHC-P)(1:50-200)
IF(IHC-F)(1:50-200)
IF(ICC)(1:50-200)

Predicted Molecular Weight: 62


Cross Reactive Species: Human
Pig

Predicted Cross Reactive Species: Rabbit

For research use only. Not intended for diagnostic or therapeutic use.

PRODUCT SPECIFIC PUBLICATIONS
  • aijin Xia. et al. Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T?cell lymphoma treatment. MOL THER-ONCOLYTICS. 2023 Sep;30:86-102Read more>>
VALIDATION IMAGES